BAY-U3405 AN ANTAGONIST OF THROMBOXANE-A2-INDUCED AND PROSTAGLANDIN-D2-INDUCED BRONCHOCONSTRICTION IN THE GUINEA-PIG

被引:41
作者
FRANCIS, HP
GREENHAM, SJ
PATEL, UP
THOMPSON, AM
GARDINER, PJ
机构
[1] Bayer UK Ltd, Stoke Poges
关键词
BAY-U3405; GUINEA-PIG LUNG; U-46619; PGD2; BRONCOCONSTRICTION; BLOOD PRESSURE; THROMBOXANE ANTAGONIST;
D O I
10.1111/j.1476-5381.1991.tb12475.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The novel thromboxane (TX) antagonist, BAY u3405, has been evaluated against bronchoconstriction induced by the TXA2 mimetic U-46619, prostaglandin D2 (PGD2), 5-hydroxytryptamine (5-HT), leukotriene D4 (LTD4) and histamine in the guinea-pig in vivo by use of a modification of the model described by Konzett & Rossler. 2 When given intravenously (i.v.) at 30 or 100-mu-g kg-1, U-46619 caused 80% maximal bronchoconstriction in most animals. In contrast, PGD2 caused a smaller 40%-50% maximal bronchoconstriction at the highest dose tested (300-mu-g kg-1, i.v.). 3 BAY u3405, given intravenously, orally (p.o.) or by aerosol antagonized U-46619-induced bronchoconstriction in a dose-related manner. The approximate ID50 values were 600-mu-g kg-1, i.v., 1.7mg kg-1 p.o. and 0.1% w/v 20 breaths by aerosol. 4 BAY u3405 had similar inhibitory activities against U-46619-induced bronchoconstriction and hypertension suggesting that it had no preferential activity on the airways. 5 When given intravenously BAY u3405 antagonized the bronchoconstrictor effect of intravenous PGD2 with ID50 values between 30-100-mu-g kg-1. 6 The action of BAY u3405 (10 mg kg-1, p.o.) was long lasting causing significant inhibition of U-46619-induced bronchoconstriction 7 h after dosing. 7 At 1 mg kg-1, i.v., a dose that abolished the response to U-46619 and PGD2, BAY u3405 had no effect on histamine-, 5-HT- or LTD4-induced bronchoconstriction. 8 BAY u3405 potently and selectively antagonized U-46619- or PGD2-induced bronchoconstriction in the Konzett-Rossler model of guinea-pig lung function. It should therefore prove to be a useful tool for defining the role of TXA2 and PGD2 in airway diseases such as asthma.
引用
收藏
页码:596 / 602
页数:7
相关论文
共 35 条
[1]   SIGNIFICANCE OF THROMBOXANE GENERATION IN OZONE-INDUCED AIRWAY HYPERRESPONSIVENESS IN DOGS [J].
AIZAWA, H ;
CHUNG, KF ;
LEIKAUF, GD ;
UEKI, I ;
BETHEL, RA ;
OBYRNE, PM ;
HIROSE, T ;
NADEL, JA .
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 59 (06) :1918-1923
[2]   9-ALPHA,11-BETA-PROSTAGLANDIN-F2, A NOVEL METABOLITE OF PROSTAGLANDIN-D2 IS A POTENT CONTRACTILE AGONIST OF HUMAN AND GUINEA-PIG AIRWAYS [J].
BEASLEY, CRW ;
ROBINSON, C ;
FEATHERSTONE, RL ;
VARLEY, JG ;
HARDY, CC ;
CHURCH, MK ;
HOLGATE, ST .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :978-983
[3]   EFFECT OF A THROMBOXANE RECEPTOR ANTAGONIST ON PGD2-INDUCED AND ALLERGEN-INDUCED BRONCHOCONSTRICTION [J].
BEASLEY, RCW ;
FEATHERSTONE, RL ;
CHURCH, MK ;
RAFFERTY, P ;
VARLEY, JG ;
HARRIS, A ;
ROBINSON, C ;
HOLGATE, ST .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (04) :1685-1693
[4]   A COMPARISON OF THE CONTRACTILE ACTIVITY OF PGD2 AND PGF2-ALPHA ON HUMAN ISOLATED BRONCHUS [J].
BLACK, JL ;
ARMOUR, CL ;
VINCENC, KS ;
JOHNSON, PRA .
PROSTAGLANDINS, 1986, 32 (01) :25-31
[5]   PGD2 INDUCES PULMONARY HYPERRESPONSIVENESS TO ACETYLCHOLINE INVIVO IN THE GUINEA-PIG [J].
BRUNELLI, G ;
DAFFONCHIO, L ;
HERNANDEZ, A ;
SALA, A ;
OMINI, C ;
BERTI, F .
JOURNAL OF AUTONOMIC PHARMACOLOGY, 1987, 7 (03) :281-285
[6]  
CHUNG KF, 1986, J PHARMACOL EXP THER, V236, P580
[7]  
CHUNG KF, 1986, AM REV RESPIR DIS, V134, P258
[8]   ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESS AND PULMONARY INFLAMMATION IN ALLERGIC DOGS [J].
CHUNG, KF ;
BECKER, AB ;
LAZARUS, SC ;
FRICK, OL ;
NADEL, JA ;
GOLD, WM .
JOURNAL OF APPLIED PHYSIOLOGY, 1985, 58 (04) :1347-1353
[9]  
COLEMAN RA, 1981, BRIT J PHARMACOL, V74, pP913
[10]  
COLEMAN RA, 1980, BRIT J PHARMACOL, V69, pP265